77 related articles for article (PubMed ID: 1656257)
1. Precipitation of ondansetron in alkaline solutions.
Jarosinski PF; Hirschfeld S
N Engl J Med; 1991 Oct; 325(18):1315-6. PubMed ID: 1656257
[No Abstract] [Full Text] [Related]
2. Pharmaceutical development of ondansetron injection.
Leak RE; Woodford JD
Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S67-9. PubMed ID: 2533902
[TBL] [Abstract][Full Text] [Related]
3. Ondansetron: design and development of oral pharmaceutical suspensions.
Gallardo Lara V; Gallardo ML; Morales Hernandez ME; Ruiz Martinez MA
Pharmazie; 2009 Feb; 64(2):90-3. PubMed ID: 19320280
[TBL] [Abstract][Full Text] [Related]
4. pH adjustment of local anesthetic solutions with sodium bicarbonate: laboratory evaluation of alkalinization and precipitation.
Peterfreund RA; Datta S; Ostheimer GW
Reg Anesth; 1989; 14(6):265-70. PubMed ID: 2562097
[TBL] [Abstract][Full Text] [Related]
5. Stability of ondansetron hydrochloride in injectable solutions at -20, 5, and 25 degrees C.
Bosso JA; Prince RA; Fox JL
Am J Hosp Pharm; 1992 Sep; 49(9):2223-5. PubMed ID: 1388000
[TBL] [Abstract][Full Text] [Related]
6. [Ondansetron--a 5HT 3 receptor antagonist for the treatment of nausea and vomiting induced by cytostatics and radiotherapy].
Herrstedt J; Ersbøll J; Dombernowsky P
Ugeskr Laeger; 1991 Apr; 153(18):1292-5. PubMed ID: 1827555
[No Abstract] [Full Text] [Related]
7. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Trissel LA; Tramonte SM; Grilley BJ
Am J Hosp Pharm; 1991 May; 48(5):988-92. PubMed ID: 1830190
[No Abstract] [Full Text] [Related]
8. pH adjustment schedule for the amide local anesthetics.
Ikuta PT; Raza SM; Durrani Z; Vasireddy AR; Winnie AP; Masters RW
Reg Anesth; 1989; 14(5):229-35. PubMed ID: 2562094
[TBL] [Abstract][Full Text] [Related]
9. pH-adjusted local anaesthetics.
Mitchell D; Stubbs A
Med J Aust; 1992 Sep; 157(5):352. PubMed ID: 1331726
[No Abstract] [Full Text] [Related]
10. The air-liquid interface and the pH and PCO2 of alkalinized local anaesthetic solutions.
Ackerman WE; Ware TR; Juneja M
Can J Anaesth; 1992 Apr; 39(4):387-9. PubMed ID: 1314142
[TBL] [Abstract][Full Text] [Related]
11. Compatibility and availability of sodium bicarbonate in total parenteral nutrient solutions.
Henann NE; Jacks TT
Am J Hosp Pharm; 1985 Dec; 42(12):2718-20. PubMed ID: 3002174
[No Abstract] [Full Text] [Related]
12. Bicarbonate buffering of local anesthetics.
Schwab RA; Watson WA
Am J Emerg Med; 1996 May; 14(3):339. PubMed ID: 8639224
[No Abstract] [Full Text] [Related]
13. Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics.
Mitchell PL; Evans BD; Allan SG; Forgeson GV; Mak D; Neave L; Humm G; Langley G; Dickson D; Harvey VJ
N Z Med J; 1992 Mar; 105(929):73-5. PubMed ID: 1532054
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing precipitation of pH-adjusted bupivacaine solutions.
Bourget P; Bonhomme L; Benhamou D
J Clin Pharm Ther; 1990 Jun; 15(3):197-204. PubMed ID: 2164035
[TBL] [Abstract][Full Text] [Related]
15. Comment: ondansetron dosing.
Masson E
Ann Pharmacother; 1992 Jun; 26(6):843-4. PubMed ID: 1535247
[No Abstract] [Full Text] [Related]
16. [Precipitation of pH-adjusted local anesthetics with sodium bicarbonate].
Koitabashi T; Sekiguchi H; Miyao H; Kawasaki J; Kawazoe T
Masui; 1995 Jan; 44(1):15-20. PubMed ID: 7699818
[TBL] [Abstract][Full Text] [Related]
17. Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.
Kris MG; Tyson LB; Clark RA; Gralla RJ
Cancer; 1992 Aug; 70(4 Suppl):1012-6. PubMed ID: 1386282
[TBL] [Abstract][Full Text] [Related]
18. Oral ondansetron.
Oster MW
Ann Intern Med; 1991 Aug; 115(3):233. PubMed ID: 1829340
[No Abstract] [Full Text] [Related]
19. Sodium bicarbonate attenuates pain on skin infiltration with lidocaine, with or without epinephrine.
McKay W; Morris R; Mushlin P
Anesth Analg; 1987 Jun; 66(6):572-4. PubMed ID: 3034106
[No Abstract] [Full Text] [Related]
20. [Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study].
Ikeda M; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Akasaka Y; Ohta J; Suminaga M
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1905-14. PubMed ID: 1387776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
